Apparent Diffusion Coefficient Values for Neuroendocrine Liver Metastases.
Sign Up to like & getrecommendations! Published in 2020 at "Academic radiology"
DOI: 10.1016/j.acra.2020.10.024
Abstract: RATIONALE AND OBJECTIVES We aimed to investigate whether there are any differences in apparent diffusion coefficient (ADC) values obtained from liver metastases due to gastroenteropancreatic neuroendocrine tumors (GEP-NET) and adenocarcinomas. MATERIALS AND METHODS We included… read more here.
Keywords: diffusion coefficient; adcmean values; gep net; adc adcmean ... See more keywords
Clinicopathological Characteristics of Gastroenteropancreatic Neuroendocrine Tumors
Sign Up to like & getrecommendations! Published in 2022 at "Pancreas"
DOI: 10.1097/mpa.0000000000001981
Abstract: Objectives Gastorenteropancreatic neuroendocrine (GEP-NET) tumors are the second most common tumors of the gastrointestinal tract. We aimed to investigate the clinicopathological features and factors affecting the prognosis of patients with GEP-NET. Methods Clinicopathological features of… read more here.
Keywords: grade; characteristics gastroenteropancreatic; tnm stage; clinicopathological characteristics ... See more keywords
Prevalence of malnutrition and nutrition-related complications in patients with gastroenteropancreatic neuroendocrine tumours.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of neuroendocrinology"
DOI: 10.1111/jne.13116
Abstract: Cross-sectional studies report that up to 25% of people with gastroenteropancreatic neuroendocrine tumours (GEP NET) are malnourished. However, the changes in nutritional status and dietary intake over time are unknown. The present study aimed to… read more here.
Keywords: weight; gastroenteropancreatic neuroendocrine; neuroendocrine tumours; nutrition ... See more keywords
Time from first symptoms to diagnosis in GEP-NET patients: Results from a large German tertiary referral center.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.4_suppl.610
Abstract: 610Background: Patients with neuroendocrine tumors (NET) often go through a long phase between onset of symptoms and initial diagnosis. Methods: Retrospective analysis of 486 patients with GEP-NET ... read more here.
Keywords: first symptoms; time first; diagnosis; symptoms diagnosis ... See more keywords
Autofluorescence Imaging of Treatment Response in Neuroendocrine Tumor Organoids
Sign Up to like & getrecommendations! Published in 2021 at "Cancers"
DOI: 10.3390/cancers13081873
Abstract: Simple Summary Gastroenteropancreatic neuroendocrine tumors (GEP-NET) account for roughly 60% of all neuroendocrine tumors, and low/intermediate grade human GEP-NETs have relatively slow growth rates that many laboratory culture methods fail to capture. Patient-derived cancer organoids… read more here.
Keywords: treatment; gep net; response; drug response ... See more keywords
Prospective Multicentric Assessment of 68Ga-DOTANOC PET/CT in Grade 1-2 GEP-NET
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15020513
Abstract: Simple Summary Determining the most sensitive imaging technique to evaluate neuroendocrine tumors spread may have an impact on therapeutic management. The aim of this multicentric study was to prospectively assess 68Ga-DOTANOC PET/CT sensitivity compared to… read more here.
Keywords: 68ga dotanoc; grade gep; gep net; dotanoc pet ... See more keywords
Surgical Approach to Liver Metastases in GEP-NET in a Tertiary Reference Center
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15072048
Abstract: Simple Summary The choice of the surgical and therapeutic approach for patients suffering from neuroendocrine liver metastases (NELM) plays a central role in the therapeutic strategy. Whilst debulking surgery is widely accepted as an alternative… read more here.
Keywords: liver; liver surgery; gep net; liver metastases ... See more keywords
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET)
Sign Up to like & getrecommendations! Published in 2023 at "Diagnostics"
DOI: 10.3390/diagnostics13091595
Abstract: Background: Grade 3 gastro-entero-pancreatic neuroendocrine tumors (G3 GEP-NET) are poorly characterized in terms of molecular features and response to treatments. Methods: Patients with G3 GEP-NET were included if they received capecitabine and temozolomide (CAPTEM) or… read more here.
Keywords: entero pancreatic; grade gastro; gep net; gastro entero ... See more keywords